Pharma Pulse 3/7/25: Overcoming Health Data Blockages in Polypharmacy, How Insurers Responded to Disasters & more
The latest news for pharma industry insiders.
Overcoming Health Data Blockages in Polypharmacy
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, shares the strategies that should be taken to overcome health information exchange blockages.
How Insurers Responded to Disasters
In the aftermath of the fires in California and the hurricanes in the Southeast, health insurers relaxed some deadlines for members and helped affected employees.
Microsoft-OpenAI Partnership Gets UK Antitrust Clearance
The decision is a a victory for the tech giant in its bid to justify the partnership to regulators on both sides of the Atlantic.
Arrowhead Pharmaceuticals, Inc. announced presentation of preclinical data supporting the advancement of two first-in-class clinical stage, RNAi-based investigational therapeutics being developed for the treatment of obesity and metabolic diseases. The two candidates, ARO-INHBE and ARO-ALK7, have the potential to reduce body weight and fat mass with a novel mechanism of action that may lead to improved preservation of lean muscle mass compared to currently approved obesity therapies.
Love this perspective Heather Hunt! Reminded me of an article about the uses of color psychology in scientific graphs.
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
